Clinical trial
11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
NCT00932932 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- August 31, 2010
- Enrollment
- 36 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.